The Treatment of Insomnia in Primary Care: Evaluating and Improving Compliance to Clinical Practice Guidelines

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to learn if training primary care providers on treatment of insomnia can improve insomnia symptoms in patients. Researchers will compare insomnia symptoms of patients receiving care from trained practices with patients receiving care from control practices (providing care-as-usual), to see if the training helps to provide improved insomnia care. Participants will be asked to complete four questionnaires and some participants will be invited for an insomnia consultation in primary care by their primary care providers (PCP).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patient registered with a participating primary care facility and willing to provide informed consent AND

• Survey confirmed presence of insomnia symptoms at least 3 times a week during at least the last 3 weeks AND

• Survey shown increased score on the Insomnia Severity Index (ISI ≥ 11) AND

• Survey shown interference with daily functioning on the Insomnia Severity Scale.

Locations
Other Locations
Netherlands
Leiden University Medical Center (LUMC)
RECRUITING
Leiden
Contact Information
Primary
Maria C.N. Meijer
m.c.n.meijer@lumc.nl
0031 71 526 9111
Time Frame
Start Date: 2024-09-12
Estimated Completion Date: 2026-09-09
Participants
Target number of participants: 315
Treatments
Experimental: Training with pro-active identification
For detailed description of the intervention, see the separate section on interventions.
Experimental: Training without pro-active identification
For detailed description of the intervention, see the separate section on interventions.
No_intervention: Control
Care as usual according to national applicable primary guide guidelines.
Related Therapeutic Areas
Sponsors
Leads: Leiden University Medical Center

This content was sourced from clinicaltrials.gov